Associate Professor
1965-1969 B.A., Zoology, Concordia College,
Moorhead, Minnesota
1969-1972 M.S., Physiology, North Dakota State University, Fargo,
North Dakota
1972-1976 M.D., University of North Dakota School of Medicine,
Grand Forks, North Dakota
1976-1977 Internship (PGY-1) in Internal Medicine, St. Luke’s
Hospital, affiliated with the University of North Dakota
1977-1980 Residency in Neurology, University of North Dakota and the Neuropsychiatric
Institute, Fargo, North Dakota
The Safety, Tolerance, and Efficacy of Oral Administration of
AY-27,773 in the Treatment of Symptomatic Diabetic Peripheral,
Sensorimotor Polyneuropathy (Ayerst Laboratories), 1983-1985
A Double-Blind, Placebo Controlled Parallel Group Study to Evaluate
Two Dose Levels of Intranasal Sumatriptan in the Acute Treatment
of a Migraine Attack, Principle Investigator (Glaxo, Inc.), 1993-1994
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluation
Headache Pain Relief with Sumatriptan Nasal Spray (5 mg, 10 mg,
and 20 mg) Across Three Migraine Attacks, Principle Investigator
(Glaxo, Inc.), 1994-1995
An Open-Label Comparison of the Absorption Pharmacokinetics of
a Single Dose of UK-116,004 in the Presence and Absence of
a Migraine Attack, Principle Investigator (Pfizer), 1995-1996
The Efficacy and Safety of Alniditan (1.4 or 1.8 mg SC) vs
Sumatriptan (6 mg SC) in the Acute Treatment of Migraine: A
Randomized, Double-Blind,
Placebo-Controlled, Single Dose Trial (Janssen), 1996-1999
A Multicenter, Double-Blind, Randomized, Placebo-Controlled,
Parallel Group Study of the Efficacy and Safety of Oral Eletriptan
in Subjects
with Acute Migraine (Pfizer), 1996-1999
A Multicenter, Randomized, Open Label, Comparative study of
the Safety and Toleration and Efficacy of Oral Eletriptan
for Long
Term Treatment of Subjects with Acute Migraine (Pfizer),
1997-1999
Open Evaluation of the Long Term Efficacy, Safety and Tolerability
of 1.4 mg SC Alniditan in the Acute Treatment of Migraine
Attacks (Janssen), 1997-1999
A Randomized, Double-Blind, Double-Dummy, Active-Placebo
Controlled, Parallel Group Evaluation of Oral Sumatriptan
(50mg) Compared
to Oral Naproxen Sodium (275mg) on Migraine-Related Quality
of Life.
Texas Department of Health Funded Program for the care
of adults with Epilepsy.
Double blind randomized trial of cognitive effects of lamotrigine
vs topiramate in epilepsy.
Validity and reliability of digitalized patient videoclips
in computer based testing. National Board of Medical Examiners.
2000-2002
A. Articles in Journals
Engebretson, K.A. and Davison, K.L. Dieldrin Accumulation and Excretion
by Rats Fed Phenobarbital and Carbon. Bull Environ Contam Toxicol
6:391-400, 1971
Davison, K.L., Engebretson, K.A. and Cox, J.H. P,p - DDT and p,p1
- DDE Effects on Egg Production, Eggshell Thickness, and Reproduction
of Japanese Qual. Bull Environ Contam Toxicol 15 (3):265-270, 1976
Engebretson, K.A., Olson, H.W., Gascon, G.G., and Brumback, R.A.
Chondrodystrophic dwarfism with Continuous Muscle Fiber Activity
(Schwartz-Jampel Syndrome): Description of Additional Abnormalities.
Ann Aneurol 8:131, 1980
Engebretson, K.A., Brumback, R.A., Olson, W.H., Staton, R.D.,
and Wilson, H. Psychological Follow-up of Children with Schwartz-Jampel
Syndrome. Internation Neuropsychology Society Bulletin 8:16,
1980
Engebretson, K.A., Olson, W.H., Gascon, G.G., and Brumback, R.A.
Chondrodystrophic Dwarfism with Continuous Muscle Fiber Activity
(Schwartz-Jampel Syndrome). Description of Additional Abnormalities
Trans Am Neurol Assoc 105:494-496, 1980
B. Abstracts
Engebretson, K.A., Schwartz-Jampel Syndrome: Two New Cases, Fargo,
North Dakota - North Dakota Medical Association, April, 1978
Engebretson, K.A. Moyamoya disease: Presentation of Two Cases with
Neuropathologic Correlation, Bismarck, North Dakota - North Dakota
Medical Association, April, 1979
Psychological Follow-up of Children with Schwartz-Jampel Syndrome
(co-authors: R.A. Brumback, W.H. Olson, R.D. Staton, and H. Wilson).
International Neuropsychological Society Annual European Conference
- Chiaciano - Terme, Italy, June, 1980
Engebretson, K.A. and Davison, K.L. Dieldrin Accumulation and Excretion
by Rats Fed Phenobarbital and Carbon. Fed Pro 30:562. (Presented
at the North Dakota Academy of Science Meeting in Fargo, North
Dakota, April, 1971. First prize winner of the Rodger Denison student
research competition)
Engebretson, K.A., Gascon, G.G., Olson, W.H., and Brumback, R.A.
Schwartz-Jampel Syndrome: Clinical and Pharmacologic Description.
Abstract #63. Seventh National Meeting of the Child Neurology Society,
1978
Fabian, R.H., and Rasmusson, K.A. Post-traumatic Focal Dystonia.
American Academy of Neurology Meeting, 1984
C. Book Chapter
Telemedicine: Practicing in the information age.
Lippincott – Raven, 1998. “Neurology”.
|
